Innocentiv.com

1. What is it?
InnoCentive® is an exciting web-based community matching top scientists to relevant R&D challenges facing leading companies from around the globe. They provide a powerful online forum enabling major companies to reward scientific innovation through financial incentives.

InnoCentive matches top scientists to relevant research and development challenges facing leading companies around the globe, for rewards up to $100,000 USD or more.

InnoCentive is a market place.

2. Who owns it?
InnoCentive is a start-up business venture incubated through the e.Lilly division of Eli Lilly and Company, a leading innovation-driven pharmaceutical corporation. Lilly was the first seeker company at InnoCentive providing leadership on the initial InnoCentive problems and awards. InnoCentive is incorporated as an independent company, and partners with various Seeker companies in many science-driven industries to revolutionize the way scientific R&D is done.
The founding Seeker company is Eli Lilly and Company, a leading innovation-driven pharmaceutical corporation.


3. What is the business model?
InnoCentive has established an expert community of problem solvers. The Seekers get their problems posted to a global community of research scientists and then pay for the solutions to problems that are judged "the best" (so, as for the Experts' solutions, only the one deemed "best" by the Seeker will receive a financial award). The solution Seeker pays InnoCentive for this service and problem formulation expertise.


4. What problems does it solve?
Multibrain:
-Time saving
-Money saving
-Reduces the cost of R&D for the company
-Recognition for the talent of the scientists